|

Icotrokinra Clinical Trials

2 actively recruiting trials across 2 locations

Also known as: JNJ-77242113

Pipeline

Phase 3: 2

Top Sponsors

  • Janssen Research & Development, LLC2

Indications

  • Arthritis2
  • Arthritis, Psoriatic2

Glendale, Arizona1 trial

A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced Participants With Active Psoriatic Arthritis

AARA Clinical Research

Phase 3

Jonesboro, Arkansas1 trial

A Study to Evaluate the Efficacy and Safety of JNJ-77242113 (Icotrokinra) in Biologic-naïve Participants With Active Psoriatic Arthritis

Arthritis and Rheumatism Associates ARA Jonesboro

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.